Managing patients with asthma continues to grow more complex. Two key guidelines have recently been updated. Where do their recommendations concur? Where do they differ, and why? Where do the newer biologic agents fit into evolving treatment paradigms? Which patients are likely to benefit, and in which are specific biologics inappropriate?
These are some of the questions we discuss with Dr. Ashraf Fawzy, from the Division of Pulmonology and Critical Care at Johns Hopkins University, in this ePulmonology Review podcast.
Assistant Professor of Medicine
Division of Pulmonary and Critical Care
Johns Hopkins University
Professor of Medicine, Epidemiology and Environmental Health Sciences
Johns Hopkins University School of Medicine
Senior Clinic Nurse Coordinator
Johns Hopkins Medicine
0.5 hour Physicians
0.5 contact hour Nurses
Launch date: January 31, 2022
Expiration date: January 30, 2024